Combined initiative announced for drop in anti-AIDS treatment costs
Thursday 25 August 2005
Home About PlusNews Country Profiles News Briefs Special Reports Subscribe Archive IRINnews


East Africa
Great Lakes
Horn of Africa
Southern Africa
West Africa
RSS - News Briefs


PlusNews E-mail Subscription

AFRICA: Combined initiative announced for drop in anti-AIDS treatment costs

[This report does not necessarily reflect the views of the United Nations]

JOHANNESBURG, 6 April (PLUSNEWS) - The Global AIDS Fund, the World Bank, the UN Children's Fund (UNICEF) and the Clinton Foundation announced on Tuesday that they would join forces to enable developing countries to purchase high-quality anti-AIDS medicines and equipment for HIV/AIDS tests at the lowest prices.

UNICEF executive director, Carol Bellamy, said: "This new partnership works to break down some of the barriers, such as price, supply and demand, that are impeding access to life-saving AIDS medicines and diagnostics in developing countries. UNICEF is very proud to be part of this creative initiative that promises to save lives and bring hope to millions of children and families around the world."

If the initiative succeeds, generic drugs made by Indian and South African pharmaceutical companies could reach virtually every poor country at less than 50 percent of currently prices.

"We regard AIDS as being the single most important issue at the moment in Africa, because of the devastating effect that it has had throughout the continent," World Bank President James Wolfensohn, said.

"This initiative will help to get treatment to those most in need - the world's poorest people. The World Bank is pleased to be a partner in the programme and fully supports it," he added.

The prices for drugs negotiated by the Clinton Foundation were announced in October 2003 and have since been available to 16 countries in Africa and the Caribbean where the Foundation's HIV/AIDS initiative is active.

The drug manufacturers named in the announcement included South Africa's Aspen Pharmacare and four Indian companies: Cipla, Ranbaxy Laboratories, Hetero Drugs, and Matrix Laboratories.

In January this year, the Clinton Foundation said it had brokered deals with diagnostics companies to provide testing machines, chemicals and training in a dozen African and Caribbean countries at discounts of up to 80 percent on market prices.

Under the Clinton Foundation drug agreement, countries wanting to get cut-price medicines would have to build up health systems to deliver them to patients, and prevent diversion of the drugs to rich countries, where they could be resold at sizable profits.


Recent AFRICA Reports
Erratic infant formula supply puts PMTCT at risk,  19/Aug/05
IRIN PlusNews Weekly Issue 247, 19 August 2005,  19/Aug/05
The plight of rape victims endures,  19/Aug/05
Poverty and gender inequality negating anti-HIV/AIDS efforts,  18/Aug/05
Camp Sizani: opening the door to life skills,  17/Aug/05
Le portail d'informations générales de la Côte d’Ivoire
Sida Info Services
Le Fonds mondial de lutte contre le SIDA, la tuberculose et le paludisme
Le Réseau Afrique 2000

PlusNews does not take responsibility for info in links supplied.

[Back] [Home Page]

Click here to send any feedback, comments or questions you have about PlusNews Website or if you prefer you can send an Email to Webmaster

Copyright © IRIN 2005
The material contained on comes to you via IRIN, a UN humanitarian news and information service, but may not necessarily reflect the views of the United Nations or its agencies.
All PlusNews material may be reposted or reprinted free-of-charge; refer to the IRIN copyright page for conditions of use. IRIN is a project of the UN Office for the Coordination of Humanitarian Affairs.